lsolalion 01 Ihe endocr~ne cell precursors lrom the tiurnan felai pancreas is Important lor the undersland~ng 01 Islet cytod~fferent~al~on The progcnltor cells, lrom wtlich all lour islet endocr~ne cell types arlse, are presenl w~t h~n tile ep~thelium of the fetal H~stociietnical staiiilng revealed vety hlgh acid 1%-galactosidasc act~vily in most cells wllI!ln tllc clusters. Alter Irany>larital~oii i~ito altlyrnlc nude [nice. Ilis clusters gave rlse to tissue rich in d~fferentiated endocrine cells. The histochern~cal find~ng of high ac~d p galactosidase actlv~ly was confirmed by d~recl measurement of lysosamal enzyme activities, It1 add~l~oli, we lound that the expresston ol a c~d 1%-galactosidase was deveiopmentally regulaled, peaking at 18-24 weeks gestation and declining to low levels In adult islets Using a fluorogenic p.galactosidase substrate, we were able lo enrich for a subpopulation of cells hlgh In a c~d (3-galactos~dase act~vity with llow cytomelty. Evidence ~denlilyng these cells as pote~itial islct cell precursors tncluded, besides the transplanlation experiments. Ihe coiocal~zat~on In 'v~tro of tyros~ne hydroxylase, a known marker of emblyon~c ~slct celis Thus, our r~s~i l l s indicale lhat hlgh acd Il-galactostdase activity serves as a lnarkcr lo enricli poptilaltons 01 endocrine cell precursors.
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B r e n d e l , R. A l e j a n d r o and J. N e r u p , S t e n o D i a b e t e s C e n t e r , 2820 G e n t o f t e , D e n m a r k a n d D i a b e t e s R e s e a r c h I n s t i t u t e , U n i v e r s i t y o f Miami, M i a m i , FL 33101, U S A T h e c y t o k i n e IL-1 0 inhibits rodent 0-cell function i n a time-a n d dose-dependent m a n n e r a n d h a s b e e n ~m p l i c a t e d a s effector molecule ~n t h e I D D M pathogenesis. In isolated rat islets IL-1 toxicity t o O-cells is dependent o n generation o f free nitric oxide radicals. Nicotinamide (NA). a free radical s c a v e n g e r a n d inhibitor o f p o l y -A D P -r i b o s e synthetase p r e v e n t s m a c r o p h a g e m e d i a t e d islet cell destruction a n d a u t o i m m u n e diabetes i n the NOD m o u s e , a n d N A s h o w s promising preventive effects i n prediabetic h u m a n s . H e r e w e studied I L -I sensitivity and N A protection of isolated h u m a n islets using a completely tntra-species i n vitro system: A 2 4 hr h u m a n islet e x p o s u r e t o authentic recombinant h u m a n IL-I 0 A 6 h r h u m a n islet I L -I exposure already leads t o a 3 0 % d e c r e a s e of insulin accumulation while i n rat islets functional i n h~b i t i o n i s s e e n only after 2 4 h r s o f IL-1 exposure . I n conclusion isolated h u m a n islets are m o s t sensitive t o IL-1 i n d u c e d O-cell suppression a n d N A protects h u m a n islet function against the IL-1 attack. The development of 0verweig;lt has recently been recognized as a common finding especially in adolecents with IDDM. However, both normal longitudinal growth and the prevention of overweight are major goals in pediatric diabetology. We therefore investigated, how genetic factors contribute to this undesirable event.
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GENETIC INFLUENCES ON HEIGHT AND WEIGHT IN CHILDREN I ADOLESCENTS WlTH TYPE-I DIABETES MELLITUS (IDDM
At the tlme of diagnosis, children with type-l diabetes are lean and slightly tailer than average (SD-scores: height: +0.51+0.07; weight: t 0 . 3 3~0 . 0 6 ; BMI: +0.08+0.05; n=251, meanZSE). However, alter > I 0 years, a significant portion of the patients loose height and become overweight: (height: -0.1620.08; weight: t0.77+0.09, BMI: +1.10+ 0.1; n=87). In a subgroup of 156 patients (74 boys, 82 girls, mean age 13.5 years), height and weight of both parents was measured at our in8titutlon. Height-SDS was +0.21 ~0 . 0 9 for fathers and +0.22+0.08 for mothers. Tho correlation between midparental height and height-SDS in the patients (+0.19+0.08) was highly significant (r=0.41, p<0.0001). In contrast, patients with IDDM were considerably more overweight (SD-score: +0.83+0.01) compared to their parents (+0.28*0.1 for lathers and t0.41Z0.1 for mothers), and weight correlated only weakly between parents and IDDM children (r=0.20, p<0.05). This correlation was significantly stronger in boys (r=0.31, p<0.001) compared to girls (r=0.10, n.5.). Interestingly, in IDDM girls, the SD-score for weight increased slgniflcantly with age (r=0.28, p<0.01), but not in boys (r=0.18, n.s.). The age 01 menarche in the mothers (13.3 + 0.1 years) was not different from their daughters (13.4 * 0.3 years). Conclusion: In IDDM airls. obesitv is orimar~lv due to factors related to the dlsease, whlle genet c predispos~t on plays a m ncr role In contrast, wlth modern therapeut c reglmen, stunted grown or aclavea puberty 1s no lonaer a major problem, as height in iDDM children-strongly reliects their gdnetic potential.
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RELATIONSHIP BETWEEN HLOOI) PRESSURE AND MICROALHUMINURIA IN ADOLESCENTS WlTH TYPE 1 DIAHETES MELLITUS
Thc u l m of thrs study war to dctcrrnlnc thc rotc ol increased blood prcssuic (BP) ~n the development of incipient diabcitc nephropdhy ~n ihc young in 1985 wc staitcd a comprchenitvc program ior c,\ily dcicit~<,n 01 Lldncy dixasc ~n diabctic childrcn and adolcscrntr This program conslstcd ol rcguiri rnc.l\urcmcnt ol uiinilry dlbumln cxcrction (UAE) by RIA mcthod (cvcry 6 months) ;arid BP (cvciy 3 months). Unstcrilc urinc wcrc excluded; BP was measurcd lollowing the crlieiia of lhc A m c r l~r n Acadcmy ol Pediatrtcs.
Glycemic and metabolic control was as~xscd cvciy 3 months by measuring HbAlc, serum cholesterol and triglyccridcs During the follow-up 11 rdolesccnts and young adults (age 14-22 yr, duration of diabetes 93~19.7 yr) developed perxistcnl microalbuminurra, dcfined as UAE greater than 30 ugimidl.73 m2 in at lcast two out of three consecutive mcilsurcmcnts, at the beginning of the study these patients had U A E and BP in ~h c normal rangc (UAE: 5-12 ugiminil.73 m2; systolic BP: 108-123 mmHg; diastolic BP. 70~82 mmHg). Diabcticr with microalbuminuria had normal systolic and dtastolic BP durine thc first "car of U A E ncrstst~nelv .
-.
in Lhc microalbum>nur~c rangc A scgnllicant Increase of both systotlc and diastolic BP bccame evident during the fourth ycar of persistent microalbuminuria. M>croalbum~nuric diabetics had . .
poorer long-term glycemic control than ~normoalhuoiinuric paticnis (matched lor sex, age and durrllon of dlabcter)(7-ycar HhAl' 9.2 i 13 vs S 3 L 12, p<(103); sciurn cholc5tcrol wa$ highcr ~n diabetics with mtcroalhumlourlo 1ncrc;isc 01 BP scenir 10 clcvclop after that per$istcnl microalbuminuria becomc5 cvtdcnl, Ihcrc;dtcr, clcv,btcd RP <.in cunir~hutc to ihc dcvclopmenl of clinical diabetic nephropathy and end \iagc rcr1.d I~~l u r c 
P R O R E N I N (PR) A N D D I A B E T I C N E P H R O P A T H Y (DN)
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